Nanoparticles Based on Chitosan Derivatives - Advances in Biomaterials Science and Biomedical Applications - page 250

Zeta
potential
(mV)

Gelling
agent

Diameter
(nm)

Polymer Drug Reference

TPP insulin 140-210 19-31 [23]

chitosan-NAC

DNA DNA 75-120 2-20 [34]

chitosan-TGA

TPP none 268 4-19 [22]

chitosan-TBA

chitosan-TBA TPP none 240 5-11 [21]

thiolated
HA

thiolated TMC OVA 250-350 10-20 [28]

chitosan-TGA none pSEAP 212-113 4-8 [33]

TPP calcitonin 230-330 21-27 [20]

glycol chitosan-TGA

Table 2. Main characteristics of nanoparticles based on thiolated chitosan derivatives